EMA defers decision on MS drug Laquinimod

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

EMA defers decision on MS drug Laquinimod

Postby MSUK » Mon Dec 23, 2013 2:15 am

The Committee for Medicinal Products for Human Use of the European Medicines Agency (EMA) decided on Friday to defer a decision on Laquinimod, an oral treatment for relapsing-remitting multiple sclerosis (RRMS). Laquinimod is being developed jointly by Teva Pharmaceutical Industries Ltd, and Swedish company Active Biotech. According to Active Biotech, the EMA will issue an opinion at its January, 2014 meeting...... Read More - [url]http://www.ms-uk.org/laquinimod
MS-UK - http://www.ms-uk.org/
User avatar
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 3:00 pm


Return to General Discussion


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service